Worthington M G, Opie L H
Ischaemic Heart Disease Research Unit of the Medical Research Council, Cape Town, South Africa.
Cardiovasc Drugs Ther. 1992 Dec;6(6):597-604. doi: 10.1007/BF00052561.
The hypothesis tested was that enhanced entry of calcium into cardiac cells would increase the susceptibility to ventricular fibrillation as measured by the ventricular fibrillation threshold (VFT) of the isolated perfused rat heart. Bay-K-8644 was used as a calcium-channel agonist. There was a biphasic effect with a maximal increase in left ventricular systolic pressure and oxygen uptake at a concentration of 10(-7) M. The same concentration caused a major reduction in the VFT. The bell-shaped pattern of fall of the VFT was inversely related to the effect on LV developed pressure. The changes in VFT could be dissociated from those on myocardial metabolites. Although Bay-K-8644 increased the heart rate, reduction of the VFT could also be obtained in paced hearts. The addition of ryanodine, an agent known to interrupt intracellular recycling of calcium through the sarcoplasmic reticulum, was able to abolish approximately half the effect of Bay-K-8644 on the VFT. Therefore, increased entry of calcium via the calcium channel is able to reduce VFT, acting in part through enhanced recycling of calcium through the sarcoplasmic reticulum.
所检验的假设是,通过离体灌注大鼠心脏的室颤阈值(VFT)来衡量,心肌细胞内钙内流增加会增加心室颤动的易感性。Bay-K-8644用作钙通道激动剂。在浓度为10^(-7) M时出现双相效应,左心室收缩压和氧摄取量最大程度增加。相同浓度导致VFT大幅降低。VFT下降的钟形模式与对左心室舒张末压的影响呈负相关。VFT的变化与心肌代谢产物的变化无关。尽管Bay-K-8644增加了心率,但在起搏心脏中也可降低VFT。添加已知可中断钙通过肌浆网进行细胞内再循环的药物ryanodine,能够消除Bay-K-8644对VFT影响的大约一半。因此,通过钙通道增加钙内流能够降低VFT,部分作用是通过增强钙通过肌浆网的再循环来实现的。